Full Text
Why Do ‘True’ Orphan Medicines Have Such A Low Acceptance Rate When Assessed By The SMC?

Abstract

Authors

P Morten A Ulrich R Le Fevre LA Eddowes

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×